Breaking News Instant updates and real-time market news.

2022-07-06 10:55:03 ABNB Airbnb $93.07 / -2.86 (-2.98%) 10:55 07/06/22 07/06 10:55 07/06/22 10:55	Airbnb put volume heavy and directionally bearish Bearish flow noted in Airbnb with 9,114 puts trading, or 1.2x expected. Most active are Jul-22 90 puts and 7/8 weekly 95 puts, with total volume in those strikes near 4,900 contracts. The Put/Call Ratio is 2.36, while ATM IV is up nearly 2 points on the day. Earnings are expected on August 2nd.

2022-07-06 10:55:03

ABNB

Airbnb

$93.07 / -2.86 (-2.98%)

10:55

07/06/22

07/06

10:55

07/06/22

10:55

Airbnb put volume heavy and directionally bearish

Bearish flow noted in Airbnb with 9,114 puts trading, or 1.2x expected. Most active are Jul-22 90 puts and 7/8 weekly 95 puts, with total volume in those strikes near 4,900 contracts. The Put/Call Ratio is 2.36, while ATM IV is up nearly 2 points on the day. Earnings are expected on August 2nd.

OTHER BREAKING NEWS FROM THE FLY

Earnings	BTCS reports Q2 EPS (61c) vs (89c) last year » 08:36 08/12/22 08/12 08:36 08/12/22 08:36 BTCS BTCS $1.75 / -0.09 (-4.89%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BTCS BTCS $1.75 / -0.09 (-4.89%) 07/05/22 BTCS appoints Adele Carey as VP, investor relations 05/17/22 BTCS to join panel discussing cryptocurrency hosted by FORCE Family Office 05/11/22 BTCS adds Axie Infinity to blockchain infrastructure operations 04/27/22 BTCS adds Kava to its blockchain infrastructure operations BTCS BTCS $1.75 / -0.09 (-4.89%) 03/28/22 H.C. Wainwright BTCS initiated with a Buy at H.C. Wainwright BTCS BTCS $1.75 / -0.09 (-4.89%) 05/16/22 BTCS reports Q1 EPS (47c) vs ($2.43) last year 03/14/22 BTCS reports 2021 EPS ($3.09) vs. (86c) last year
Earnings	Biofrontera Inc. expects 2022 revenue up at least 30% vs. 2021 » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) Biofrontera Inc. affirms… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08/01/22 Biofrontera announces patent in Australia for novel illumination protocols 07/27/22 Biofrontera Inc. announces exercise of existing warrants 07/12/22 Biofrontera Inc. sees Q2 product revenue $4.4M-$4.6M 05/16/22 Biofrontera Inc. announces pricing of $9.4M private placement BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 12/30/21 Benchmark Biofrontera AG financial reporting may now change, says Benchmark 12/15/21 Benchmark Biofrontera initiated with a Buy at Benchmark 11/24/21 Roth Capital Roth Capital bullish on Biofrontera, initiates with a Buy 11/24/21 Roth Capital Biofrontera initiated with a Buy at Roth Capital BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08:35 Today Biofrontera Inc. reports Q2 EPS (5c) vs. (46c) last year 05/13/22 Biofrontera Inc. reaffirms FY22 revenue view up at least 30% vs 2021 05/13/22 Biofrontera Inc. reports Q1 EPS 32c vs (44c) last year 04/08/22 Biofrontera Inc. sees 2022 revenue up 30% vs. 2021 29 Oct BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 04/08/22 Fly Intel: Pre-market Movers 11:00 Today Biofrontera Inc. - BFRI BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/11/22 Eighteen new option listings on May 11th
Earnings	PhaseBio reports Q2 EPS (34c) vs. (60c) » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 PHAS PhaseBio $1.19 / +0.05 (+4.39%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 PhaseBio announces successful Pre-BLA meeting with U.S. FDA for bentracimab 04/04/22 PhaseBio: primary reversal endpoint in achieved bentracimab Phase 2b trial 03/08/22 PhaseBio completes bentracimab PPQ campaign PHAS PhaseBio $1.19 / +0.05 (+4.39%) 10/13/21 Stifel PhaseBio resumed with a Buy at Stifel PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 PhaseBio reports Q1 EPS (23c), consensus (66c) 03/24/22 PhaseBio reports Q4 EPS (90c), consensus (59c) PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 Fly Intel: Pre-market Movers
Earnings	Biofrontera Inc. reports Q2 EPS (5c) vs. (46c) last year » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) Reports Q2 revenue $4.5M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08/01/22 Biofrontera announces patent in Australia for novel illumination protocols 07/27/22 Biofrontera Inc. announces exercise of existing warrants 07/12/22 Biofrontera Inc. sees Q2 product revenue $4.4M-$4.6M 05/16/22 Biofrontera Inc. announces pricing of $9.4M private placement BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 12/30/21 Benchmark Biofrontera AG financial reporting may now change, says Benchmark 12/15/21 Benchmark Biofrontera initiated with a Buy at Benchmark 11/24/21 Roth Capital Roth Capital bullish on Biofrontera, initiates with a Buy 11/24/21 Roth Capital Biofrontera initiated with a Buy at Roth Capital BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/13/22 Biofrontera Inc. reaffirms FY22 revenue view up at least 30% vs 2021 05/13/22 Biofrontera Inc. reports Q1 EPS 32c vs (44c) last year 04/08/22 Biofrontera Inc. sees 2022 revenue up 30% vs. 2021 04/08/22 Biofrontera Inc. reports Q4 EPS ($1.29) vs. ($2.12) last year 29 Oct BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 04/08/22 Fly Intel: Pre-market Movers 11:00 Today Biofrontera Inc. - BFRI BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/11/22 Eighteen new option listings on May 11th
Earnings	Point Biopharma reports Q2 EPS (27c), consensus (22c) » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 PNT Point Biopharma $8.09 / -0.91 (-10.11%) "We continue to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PNT Point Biopharma $8.09 / -0.91 (-10.11%) 08/08/22 Point Biopharma to host investor education event on August 18 06/21/22 Point Biopharma appoints Horvath as EVP, Commercial 05/16/22 Point Biopharma unveils FRONTIER: pan-cancer clinical program 05/13/22 Point Biopharma sees cash, equivalents funding operations into 1Q24 PNT Point Biopharma $8.09 / -0.91 (-10.11%) 07/06/22 William Blair William Blair starts Point Biopharma at Outperform on 'superior' manufacturing 07/06/22 William Blair Point Biopharma initiated with an Outperform at William Blair 05/26/22 Jefferies Point Biopharma assumed with Buy from Hold at Jefferies 05/13/22 Piper Sandler Point Biopharma price target lowered to $14 from $17 at Piper Sandler PNT Point Biopharma $8.09 / -0.91 (-10.11%) 05/13/22 Point Biopharma reports Q1 EPS (18c), consensus (21c) 03/25/22 Point Biopharma reports Q4 EPS (16c), consensus (23c)
General news	July export prices down 3.3% vs. last month, consensus 0.1% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
General news	July export prices up 13.1% vs. last year 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
General news	July import prices up 8.8% vs. last year, consensus 9.4% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Downgrade	Mister Car Wash downgraded to Equal Weight from Overweight at Morgan Stanley » 08:34 08/12/22 08/12 08:34 08/12/22 08:34 MCW Mister Car Wash $12.00 / -0.25 (-2.04%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/03/22 Mister Car Wash acquires Top Wash in Minnesota 06/27/22 Mister Car Wash falls -5.3% 04/29/22 Mister Car Wash acquires Speedwash, terms undisclosed 03/24/22 Mister Car Wash jumps over 3% to $16.39 after Q4 earnings beat MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 06/27/22 Goldman Sachs Mister Car Wash downgraded to Sell from Neutral at Goldman Sachs 05/13/22 BMO Capital Mister Car Wash price target lowered to $18 from $23 at BMO Capital 05/13/22 Piper Sandler Mister Car Wash price target lowered to $13 from $18 at Piper Sandler 03/25/22 BMO Capital Mister Car Wash price target lowered to $23 from $25 at BMO Capital MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/11/22 Mister Car Wash cuts FY22 EPS view to 36c-39c from 44c-47c, consensus 45c 08/11/22 Mister Car Wash reports Q2 adjusted EPS 11c, consensus 12c 05/12/22 Mister Car Wash backs FY22 EPS view of 44c-47c, consensus 46c 05/12/22 Mister Car Wash reports Q1 EPS 11c, consensus 11c 24 Aug MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/11/22 Fly Intel: After-Hours Movers 05/13/22 What You Missed On Wall Street On Friday 05/13/22 What You Missed On Wall Street This Morning 03/25/22 What You Missed On Wall Street On Friday
General news	July import prices down 1.4% vs. last month, consensus down 0.9% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday

Hot Stocks	Acer Therapeutics, Relief receive orphan drug designation for ACER-001 » 08:33 08/12/22 08/12 08:33 08/12/22 08:33 ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) , RLFTF Relief / + RELIEF THERAPEUTICS… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ACER RLFTF ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 07/28/22 Relief, Acer announce submit IND application to FDA for ACER-001 in MSUD 07/28/22 Relief, Acer announce FDA acceptance of review for ACER-001 NDA resubmission 07/18/22 Acer Therapeutics resubmits NDA for ACER-001 for treatment of UCDs 07/08/22 Acer, Relief announces utility model patent issuance for ACER-001 by CNIPA RLFTF Relief / + 07/28/22 Relief, Acer announce submit IND application to FDA for ACER-001 in MSUD 07/28/22 Relief, Acer announce FDA acceptance of review for ACER-001 NDA resubmission 07/08/22 Acer, Relief announces utility model patent issuance for ACER-001 by CNIPA 06/21/22 Acer Therapeutics, Relief announce update on FDA review of NDA for ACER-001 ACER RLFTF ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 01/11/22 H.C. Wainwright Acer Therapeutics assumed with a Buy at H.C. Wainwright 10/06/21 William Blair Acer Therapeutics set up for 'major event' with NDA accepted, says William Blair RLFTF Relief / + 10/06/21 William Blair Acer Therapeutics set up for 'major event' with NDA accepted, says William Blair ACER ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 03/02/22 Acer Therapeutics reports Q4 EPS (31c), consensus (1c) 01/15/23 PDUFA Date for ACER-001
Hot Stocks	AGBA Acquisition extends consummation period for business combination » 08:33 08/12/22 08/12 08:33 08/12/22 08:33 AGBA AGBA Acquisition $11.37 / + (+0.00%) AGBA Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	TerrAscend downgraded to Hold from Buy at Craig-Hallum » 08:32 08/12/22 08/12 08:32 08/12/22 08:32 TRSSF TerrAscend $2.40 / +0.11 (+4.80%) Craig-Hallum analyst Eric… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 06/02/22 TerrAscend debuts Cookies, Gage brands in New Jersey 03/09/22 TerrAscend to close Gage Growth acquisition on March 10 TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 07:30 Today Cantor Fitzgerald TerrAscend downgraded to Neutral from Overweight at Cantor Fitzgerald 07/22/22 Seaport Global TerrAscend initiated with a Buy at Seaport Global 02/09/22 Clarus TerrAscend price target lowered to C$14 from C$16.25 at Clarus 12/08/21 Cantor Fitzgerald TerrAscend price target raised to $7.65 from $6.70 at Cantor Fitzgerald TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 04/14/22 Here's What You Missed in Cannabis This Week
Recommendations	State Street price target raised to $74 from $67 at Deutsche Bank » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 STT State Street $73.51 / +1 (+1.38%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options STT State Street $73.51 / +1 (+1.38%) 07/21/22 State Street appoints Brenda Tsai as global chief marketing officer 07/15/22 State Street raises FY22 NII view to up 24%-27% from up 18%-20% 07/15/22 State Street sees Q3 NII up 5%-9% 07/15/22 State Street says raising prices across services STT State Street $73.51 / +1 (+1.38%) 07/18/22 Deutsche Bank State Street price target raised to $67 from $65 at Deutsche Bank 07/13/22 Deutsche Bank State Street price target lowered to $65 from $67 at Deutsche Bank 07/12/22 Citi State Street price target lowered to $69 from $93 at Citi 07/11/22 UBS State Street price target lowered to $91 from $101 at UBS STT State Street $73.51 / +1 (+1.38%) 07/15/22 State Street reports Q2 ex-items EPS $1.94 vs. $1.57 last year 07/14/22 Notable companies reporting before tomorrow's open 04/14/22 State Street reports Q1 adjusted EPS $1.59, consensus $1.47 04/13/22 Notable companies reporting before tomorrow's open 10 Sep STT State Street $73.51 / +1 (+1.38%) 06/09/22 State Street tells Bloomberg not pursuing any deal with Credit Suisse 06/09/22 State Street says not pursuing any deal with Credit Suisse, Bloomberg reports 06/09/22 Credit Suisse CEO says State Street buyout questions 'really stupid' 06/08/22 State Street tells Bloomberg not responding to Credit Suisse report STT State Street $73.51 / +1 (+1.38%) 07/15/22 What You Missed On Wall Street On Friday 07/15/22 What You Missed On Wall Street This Morning 06/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/09/22 What You Missed On Wall Street On Thursday STT State Street $73.51 / +1 (+1.38%) 07/15/22 Early notable gainers among liquid option names on July 15th
Recommendations	Invesco price target raised to $20 from $18 at Deutsche Bank » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 IVZ Invesco $18.49 / +0.2925 (+1.61%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly IVZ Invesco $18.49 / +0.2925 (+1.61%) 08/09/22 Invesco reports preliminary AUM $1.45T as of July 31 07/12/22 Invesco reports preliminary AUM $1.39T as of June 30 07/07/22 Invesco Real Estate Income acquires two self-storage portfolios for $42M 06/09/22 Invesco reports AUM of $1.4516B as of May 31, 2022 IVZ Invesco $18.49 / +0.2925 (+1.61%) 07/18/22 JPMorgan Invesco price target lowered to $20 from $22 at JPMorgan 07/13/22 Deutsche Bank Invesco price target lowered to $19 from $21 at Deutsche Bank 07/11/22 UBS Invesco price target lowered to $21 from $27 at UBS 06/28/22 Keefe Bruyette Invesco price target lowered to $18 from $21 at Keefe Bruyette IVZ Invesco $18.49 / +0.2925 (+1.61%) 07/27/22 Invesco reports Q2 adjusted EPS 39c vs. 67c last year 06/20/22 Fly Intel: Top five weekend stock stories 04/26/22 Invesco reports Q1 adjusted EPS 56c, consensus 58c IVZ Invesco $18.49 / +0.2925 (+1.61%) 06/18/22 BlackRock, T. Rowe Price worth a look, Barron's says 05/18/22 GOP looks to curb voting power of BlackRock, other asset managers, WSJ reports IVZ Invesco $18.49 / +0.2925 (+1.61%) 06/13/22 What You Missed On Wall Street On Monday 06/13/22 Fly Intel: Pre-market Movers
Options	One new option listing and one option delisting on August 12th » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 SLAC Social Leverage Acquisition Corp I $9.86 / + (+0.00%) , SYNL Synalloy / + New option listings for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings SLAC SLAC Social Leverage Acquisition Corp I $9.86 / + (+0.00%) 08/01/22 W3BCLOUD to become public through Social Leverage Acquisition Corp I combination SYNL SYNL Synalloy / + 08/09/22 Synalloy reports Q2 EPS $1.06 vs. 31c last year 05/10/22 Synalloy reports Q1 EPS 99c vs. 12c last year
Recommendations	Robinhood price target raised to $10 from $9 at Deutsche Bank » 08:29 08/12/22 08/12 08:29 08/12/22 08:29 HOOD Robinhood $10.51 / -0.08 (-0.76%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/08/22 Robinhood exec sells $1.18M in common stock 08/04/22 Robinhood CEO says in 'great position as a stand-alone company' 08/04/22 SEC probing Robinhood compliance with short selling rules 08/02/22 Robinhood sees FY22 operating expenses $1.7B-$1.76B HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/04/22 Deutsche Bank Robinhood price target raised to $9 from $8 at Deutsche Bank 08/04/22 Mizuho Robinhood price target lowered to $13 from $14 at Mizuho 08/03/22 Piper Sandler Robinhood price target lowered to $10 from $11 at Piper Sandler 07/25/22 JPMorgan JPMorgan sees increased share dilution risk for Coinbase, Robinhood HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/03/22 Notable companies reporting after market close 08/02/22 Robinhood reports Q2 EPS (34c), consensus (37c) 04/28/22 Robinhood reports Q1 EPS (45c), consensus (36c) 04/28/22 Notable companies reporting after market close HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/11/22 Judge rules Robinhood must face market manipulation claims, Reuters says 07/20/22 Study finds Robinhood cause of phantom surge in Berkshire Hathaway, WSJ reports 06/27/22 Bankman-Fried says FTX not in active M&A talks with Robinhood, WSJ says 06/27/22 FTX deliberating about potential of deal to buy Robinhood, Bloomberg says HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/11/22 What You Missed On Wall Street On Thursday 08/05/22 Here's What You Missed in Crypto This Week 08/03/22 Fly Intel: After-Hours Movers 08/03/22 What You Missed On Wall Street On Wednesday HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/08/22 Robinhood Markets call volume above normal and directionally bullish 08/05/22 Unusually active option classes on open August 5th 08/04/22 Robinhood Markets call volume above normal and directionally bullish 08/04/22 Unusually active option classes on open August 4th
Recommendations	CorMedix price target lowered to $16 from $27 at Truist » 08:28 08/12/22 08/12 08:28 08/12/22 08:28 CRMD CorMedix $3.72 / +0.345 (+10.22%) Truist analyst Joon Lee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CRMD CorMedix $3.72 / +0.345 (+10.22%) 08/11/22 CorMedix expects cash to fund operations at least through 3Q23 08/08/22 CorMedix receives CRL from FDA saying that DefenCath NDA cannot be approved 05/12/22 CorMedix believes it has sufficient resources to fund through 1H of 2023 05/12/22 CorMedix announces leadership updates, operational changes CRMD CorMedix $3.72 / +0.345 (+10.22%) 08/09/22 JMP Securities CorMedix price target lowered to $14 from $19 at JMP Securities 08/09/22 Needham CorMedix price target lowered to $12 from $20 at Needham CRMD CorMedix $3.72 / +0.345 (+10.22%) 08/11/22 CorMedix reports Q2 EPS (19c), consensus (21c) 05/12/22 CorMedix reports Q1 EPS (18c), consensus (22c) 03/29/22 CorMedix reports Q4 EPS (20c), consensus (23c) CRMD CorMedix $3.72 / +0.345 (+10.22%) 08/08/22 Fly Intel: After-Hours Movers 03/29/22 Fly Intel: After-Hours Movers
Recommendations	Franklin Resources price target raised to $29 from $26 at Deutsche Bank » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 BEN Franklin Resources $28.68 / +0.295 (+1.04%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals BEN Franklin Resources $28.68 / +0.295 (+1.04%) 08/09/22 Franklin Resources reports AUM of $1.43T as of July 31, 2022 07/12/22 Franklin Resources reports preliminary AUM $1.379T as of June 30 06/09/22 Franklin Resources reports preliminary AUM $1.45T as of May 31 05/31/22 Franklin Templeton to acquire Alcentra from BNY Mellon in accretive transaction BEN Franklin Resources $28.68 / +0.295 (+1.04%) 07/11/22 UBS Franklin Resources price target lowered to $24 from $27 at UBS 06/28/22 Keefe Bruyette Franklin Resources downgraded to Underperform at Keefe Bruyette 06/28/22 Goldman Sachs Franklin Resources reinstated with a Sell at Goldman Sachs 06/01/22 BMO Capital Franklin Resources price target lowered to $27 from $29 at BMO Capital BEN Franklin Resources $28.68 / +0.295 (+1.04%) 07/28/22 Franklin Resources reports Q3 EPS 82c, consensus 75c 06/20/22 Fly Intel: Top five weekend stock stories 05/03/22 Franklin Resources reports Q2 adjusted EPS 96, consensus 82c BEN Franklin Resources $28.68 / +0.295 (+1.04%) 06/18/22 BlackRock, T. Rowe Price worth a look, Barron's says
Technical Analysis	DJ Transportation Average: Pivot points » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 $DJT DJ Transportation Average / + The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Technical Analysis $DJT DJ Transportation Average / + 06/07/22 Global growth to fall to 2.9% in 2022 from 5.7% in 2021, World Bank says $DJT DJ Transportation Average / + 08/11/22 DJ Transportation Average: Pivot points 08/10/22 DJ Transportation Average: Pivot points 08/09/22 DJ Transportation Average: Pivot points 08/08/22 DJ Transportation Average: Pivot points

Technical Analysis	DJ Utility Average: Pivot points » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 $DJU DJ Utility Average / + The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $DJU DJ Utility Average / + 08/11/22 DJ Utility Average: Pivot points 08/10/22 DJ Utility Average: Pivot points 08/09/22 DJ Utility Average: Pivot points 08/08/22 DJ Utility Average: Pivot points
Recommendations	Janus Henderson Group price target raised to $26 from $23 at Deutsche Bank » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 JHG Janus Henderson Group $25.97 / +0.165 (+0.64%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings JHG Janus Henderson Group $25.97 / +0.165 (+0.64%) 06/21/22 Janus Henderson Group announces Ali Dibadj as CEO 05/14/22 Trian exits Comcast position, increases stake in Invesco 05/04/22 Janus Henderson Group announces new $200M share buyback program 03/23/22 Janus Henderson announces Ali Dibadj as next CEO JHG Janus Henderson Group $25.97 / +0.165 (+0.64%) 07/29/22 Citi Janus Henderson Group downgraded to Sell from Neutral at Citi 07/18/22 JPMorgan Janus Henderson Group downgraded to Underweight from Neutral at JPMorgan 07/13/22 Deutsche Bank Janus Henderson Group price target lowered to $23 from $24 at Deutsche Bank 06/28/22 Keefe Bruyette Janus downgraded to Underperform from Market Perform at Keefe Bruyette JHG Janus Henderson Group $25.97 / +0.165 (+0.64%) 07/28/22 Janus Henderson Group reports Q2 adjusted EPS 63c, consensus 65c 05/04/22 Janus Henderson Group reports Q1 adjusted EPS 75c, consensus 86c
Technical Analysis	Dow Jones Industrial Average: Pivot points » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 DJX Dow Jones Industrial Average / + The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Technical Analysis DJX Dow Jones Industrial Average / + 06/14/22 Ackman says 75 point hike tomorrow can help restore confidence in Fed 05/19/22 Could crypto crash be good for U.S. economy? Probably. DJX Dow Jones Industrial Average / + 02/17/22 JPMorgan JPMorgan now expects seven rate hikes in this year, up from five 01/24/22 JPMorgan JPMorgan macro strategist says market correction in final stages 11/26/21 Morgan Stanley Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley 11/26/21 Credit Suisse Concerns over new Covid variant 'understandable,' says Credit Suisse DJX Dow Jones Industrial Average / + 05/10/22 Tepper says covered Nasdaq short, CNBC reports DJX Dow Jones Industrial Average / + 08/11/22 Dow Jones Industrial Average: Pivot points 08/10/22 Dow Jones Industrial Average: Pivot points 08/09/22 Dow Jones Industrial Average: Pivot points 08/08/22 Dow Jones Industrial Average: Pivot points
Technical Analysis	iShares Transportation Average: Pivot points » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 IYT iShares Transportation Average $246.57 / +1.36 (+0.55%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Technical Analysis IYT iShares Transportation Average $246.57 / +1.36 (+0.55%) 06/07/22 Global growth to fall to 2.9% in 2022 from 5.7% in 2021, World Bank says IYT iShares Transportation Average $246.57 / +1.36 (+0.55%) 08/11/22 iShares Transportation Average: Pivot points 08/10/22 iShares Transportation Average: Pivot points 08/09/22 iShares Transportation Average: Pivot points 08/08/22 iShares Transportation Average: Pivot points
Technical Analysis	Technology Select Sector SPDR: Pivot points » 08:26 08/12/22 08/12 08:26 08/12/22 08:26 XLK Technology Select Sector SPDR $147.65 / -0.59 (-0.40%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Options Technical Analysis XLK Technology Select Sector SPDR $147.65 / -0.59 (-0.40%) 07/21/22 Truist Technology sector upgraded to neutral from underweight at Truist XLK Technology Select Sector SPDR $147.65 / -0.59 (-0.40%) 07/19/22 Unusually active option classes on open July 19th 05/10/22 Unusually active option classes on open May 10th XLK Technology Select Sector SPDR $147.65 / -0.59 (-0.40%) 08/11/22 Technology Select Sector SPDR: Pivot points 08/10/22 Technology Select Sector SPDR: Pivot points 08/09/22 Technology Select Sector SPDR: Pivot points 08/08/22 Technology Select Sector SPDR: Pivot points

Events

Earnings calls, analyst events, roadshows and more

VET
Today at 09:00

Vermilion Energy - VET Conference Calls
SIDU
Today at 09:00

Sidus Space - SIDU Conference Calls
IMH
Today at 09:00

IMPAC Mortgage - IMH Conference Calls
ICCC
Today at 09:00

Immucell - ICCC Conference Calls
BWMN
Today at 09:00

Bowman Consulting - BWMN Conference Calls
SPB
Today at 09:00

Spectrum Brands - SPB Conference Calls
Today at 10:00

Consumer Sentiment Index: August (p) 2022 Government Event
KLXE
Today at 10:00

KLX Energy - KLXE Conference Calls
WLMS
Today at 10:00

Williams Industrial Services - WLMS Conference Calls
STRR
Today at 10:00

Star Equity - STRR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity Priced at: $5.00 3M Shares REBN X REBN Reborn Coffee IPO Managers: EF Hutton Priced at: $5.00 1.44M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams Priced at: $35.00 7.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INAB X INAB In8bio Secondary Managers: H.C. Wainwright Priced at: $1.90 5.39M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler Priced at: $23.75 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INSP X INSP Inspire Medical Spot Secondary Managers: Goldman Sachs Priced at: $215.00 1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CERT X CERT Certara Spot Secondary Managers: Morgan Stanley $17.75-18.50 7M Shares
Fri	No deals

View All Syndicate Announcements »

Airbnb put volume heavy and directionally bearish

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access